STT.Shortness of Breath, Spreading Pain, and Exhaustion: Will Roberts Enters a Decisive Stage in His Treatment Battle

Ralph, Alabama –In a treatment room at Children’s of Alabama at 11:15 p.m. on a frigid February night, 14-year-old Will Roberts’ health was entering what doctors described as a “complex but temporarily stable” phase.

This information was released after two days of comprehensive imaging to assess the progression of osteosarcoma – a rare but highly invasive form of bone cancer that typically occurs in children and adolescents during their rapid growth phase.

According to medical records, osteosarcoma forms from mutated bone-forming cells that grow uncontrollably and create a malignant tumor within the bone structure.

The disease tends to appear in long bones such as the femur, tibia, and humerus, and has the potential to metastasize to the lungs or other bone sites if not controlled promptly.

In Will’s case, the initial injuries were found in his right femur.

Subsequently, the disease progressed to the tibia, left clavicle, and humerus, forcing the treatment team to employ a combination regimen of chemotherapy, surgery, and high-intensity radiation therapy.

Due to the severity of bone destruction and the risk of spreading, Will had to have one leg amputated to prevent the cancer cells from spreading further.

This was a difficult but necessary medical decision to save a life.

However, according to experts, even after amputation, osteosarcoma still has a risk of recurrence or appearing in a different location.

Therefore, regular magnetic resonance imaging (MRI) and computed tomography (CT) scans play a crucial role in monitoring the disease.

The latest imaging results show that most of the old lesions have not increased in size compared to last December.

This means that recent radiation therapies have been able to somewhat control disease progression in areas that were previously known for high activity.

However, a new lesion was discovered in the pelvic region.

According to the treating physician, the lesion is small but needs close monitoring because it is a highly vascular area and there is a risk of it spreading if the malignant cells continue to function.

The expert panel is considering a high-dose targeted radiation therapy option to destroy cancer cells at this location.

Meanwhile, Will is undergoing immunotherapy with MEPACT – a drug used to stimulate the immune system to recognize and attack any remaining cancer cells.

MEPACT works by activating macrophages, enhancing the body’s natural immune response.

According to international studies, the drug may improve survival rates in osteosarcoma patients after surgery when combined with standard chemotherapy.

In Will’s case, the drug was used on humanitarian grounds because traditional treatment options were nearing their limits of effectiveness.

Every week, he has to go to the hospital twice to receive intravenous medication for several hours.

Common side effects include mild fever, fatigue, muscle aches, and nausea.

The family said Will had gone through a period of physical exhaustion due to fluid buildup and the effects of steroids.

His body showed signs of edema in his remaining arm and leg.

The pain stems not only from the existing tumor but also from “phantom limb pain”—a sensation of pain that occurs in the amputated limb due to persistent nerve signals.

According to neurologists, this phenomenon is quite common in patients after limb amputation surgery and can last for months or even years.

Pain management requires a combination of pain medication, physical therapy, and psychological support.

In recent days, Will’s pain has reportedly improved somewhat.

He can sleep through the night without needing to increase his pain medication dosage.

Fluid tolerance also improved, indicating that the digestive system was beginning to recover after prolonged treatment periods.

However, doctors warn that the current phase still holds many uncertainties.

Osteosarcoma is known for its rapid and unpredictable recurrence.

The 5-year survival rate in patients with bone or lung metastases is significantly lower compared to those diagnosed early and without widespread metastasis.

Therefore, each imaging scan is crucial in determining the next course of treatment.

The Roberts family said they are preparing themselves for a prolonged treatment scenario.

Options may include increasing the dose of targeted radiation therapy, changing the chemotherapy regimen, or further expanding immunotherapy.

Alongside physical treatment, the clinical psychology team also closely monitored Will’s progress.

Cancer in adolescence is not only a medical challenge but also a serious psychological one.

Losing a body part, being away from school, and facing the constant risk of relapse can cause lasting trauma if not properly supported.

According to his family, Will remains in a positive mood.

He regularly updates his friends at Sipsey Valley Middle School on his progress and receives much encouragement from the local community.

Although there is no specific timeframe for returning to school, doctors encourage maintaining social connections to support mental recovery.

Currently, Will’s treatment plan is structured in short phases, based on his body’s actual response to medication.

The medical team emphasized that “stabilization” does not mean recovery, but only temporary control of a disease whose progression is unpredictable.

In this context, every small sign, such as sleeping through the night or being able to retain a sip of water, carries significant clinical importance.

The family said they would continue to provide updates on Will’s condition as new developments emerge.

Doctors have confirmed they will closely monitor the pelvic injury in the coming weeks to adjust the treatment strategy as needed.

Will Roberts’ battle with osteosarcoma is far from over.

But at this moment, the temporary stability is providing a much-needed respite from a prolonged period of tension.